Trials / Recruiting
RecruitingNCT04513054
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy: The GENETIC Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- University of Aberdeen · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.
Detailed description
Acute stress-induced (takotsubo) cardiomyopathy presents like a myocardial infarct, is triggered by intense emotional or physical stress, and can have catastrophic and potentially fatal consequences. Despite data linking takotsubo cardiomyopathy with conditions that have a recognized genetic predisposition (such as mental health and neurological problems), a systematic and comprehensive characterisation of the genetic-epidemiologic factors in takotsubo is lacking. The researchers propose to further investigate this disorder by collecting blood from probands and characterising the genotype of patients with takotsubo cardiomyopathy in a large scale, nationwide genome wide association study. The investigators will also archive DNA for identification of future candidate genetic variants. Ultimately, understanding the underlying predisposition of this poorly understood neuro-psycho-cardiac disorder is essential if we are to move this field forward.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Blood collection for genetic analysis | Blood collection for genetic analysis |
Timeline
- Start date
- 2019-03-12
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2020-08-14
- Last updated
- 2024-12-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04513054. Inclusion in this directory is not an endorsement.